×
Entrez Id:
4609
Gene Symbol:
MYC
MYC
0.300
Biomarker
disease
CTD_human
Oncogene expression of FANFT- or BBN-induced rat urothelial cells.
2228319
1990
×
Entrez Id:
999
Gene Symbol:
CDH1
CDH1
0.300
Biomarker
disease
CTD_human
Mutations of the E-cadherin gene in human gynecologic cancers.
8075649
1994
×
Entrez Id:
3265
Gene Symbol:
HRAS
HRAS
0.310
Biomarker
disease
CTD_human
Infrequent mutation of Ha-ras and p53 in rat mammary carcinomas induced by 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine.
8185828
1994
×
Entrez Id:
7157
Gene Symbol:
TP53
TP53
0.370
AlteredExpression
disease
BEFREE
Abnormalities in tumor suppressor gene p53 expression also were found in two of the 11 SpCC cases using monoclonal antibody PAb 1801.
8276377
1993
×
Entrez Id:
5020
Gene Symbol:
OXT
OXT
0.300
Therapeutic
disease
CTD_human
Oxytocin and oxytocin-analogue F314 inhibit cell proliferation and tumor growth of rat and mouse mammary carcinomas.
8647655
1996
×
Entrez Id:
7157
Gene Symbol:
TP53
TP53
0.370
GeneticVariation
disease
BEFREE
Pleomorphic (giant and spindle cell) carcinoma is genetically distinct from adenocarcinoma and squamous cell carcinoma by K-ras-2 and p53 analysis.
8853037
1996
×
Entrez Id:
3845
Gene Symbol:
KRAS
KRAS
0.360
Biomarker
disease
BEFREE
Pleomorphic (giant and spindle cell) carcinoma is genetically distinct from adenocarcinoma and squamous cell carcinoma by K-ras-2 and p53 analysis.
8853037
1996
×
Entrez Id:
3265
Gene Symbol:
HRAS
HRAS
0.310
Biomarker
disease
BEFREE
Pleomorphic (giant and spindle cell) carcinoma is genetically distinct from adenocarcinoma and squamous cell carcinoma by K-ras-2 and p53 analysis.
8853037
1996
×
Entrez Id:
1440
Gene Symbol:
CSF3
CSF3
0.300
Therapeutic
disease
CTD_human
Neurobiochemical changes from Taxol/Neupogen chemotherapy for metastatic breast carcinoma corresponds with suicidal depression.
9018096
1996
×
Entrez Id:
7253
Gene Symbol:
TSHR
TSHR
0.300
Biomarker
disease
CTD_human
Detection of an activating mutation of the thyrotropin receptor in a case of an autonomously hyperfunctioning thyroid insular carcinoma.
9062474
1997
×
Entrez Id:
7157
Gene Symbol:
TP53
TP53
0.370
GeneticVariation
disease
BEFREE
This analytical approach demonstrated p53 missense point mutations in four of nine cases of spindle cell carcinoma with a 100% concordance rate between p53 immunopositivity and the presence of DNA mutational damage.
9236836
1997
×
Entrez Id:
5728
Gene Symbol:
PTEN
PTEN
0.300
Biomarker
disease
CTD_human
PTEN1 is frequently mutated in primary endometrial carcinomas.
9326929
1997
×
Entrez Id:
7157
Gene Symbol:
TP53
TP53
0.370
Biomarker
disease
CTD_human
Human papillomavirus DNA and p53 status in penile carcinomas.
9626339
1998
×
Entrez Id:
7431
Gene Symbol:
VIM
VIM
0.040
AlteredExpression
disease
BEFREE
The tumor was detected in an 70-year-old Japanese man who presented with hematuria Histologic examination showed an undifferentiated round or spindle cell carcinoma (cytokeratin 7+, cytokeratin 20+, epithelial membrane antigen+, vimentin -) with abundant lymphocytes (predominantly UCHL-1+ T cells), plasma cells, and macrophages in and around the tumor cell nests.
9872659
1998
×
Entrez Id:
3855
Gene Symbol:
KRT7
KRT7
0.020
GeneticVariation
disease
BEFREE
The tumor was detected in an 70-year-old Japanese man who presented with hematuria Histologic examination showed an undifferentiated round or spindle cell carcinoma (cytokeratin 7 +, cytokeratin 20+, epithelial membrane antigen+, vimentin-) with abundant lymphocytes (predominantly UCHL-1+ T cells), plasma cells, and macrophages in and around the tumor cell nests.
9872659
1998
×
Entrez Id:
1447
Gene Symbol:
CSN2
CSN2
0.300
Biomarker
disease
CTD_human
mRNA differential display of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine-induced rat mammary gland tumors.
9879772
1998
×
Entrez Id:
7018
Gene Symbol:
TF
TF
0.300
Biomarker
disease
CTD_human
mRNA differential display of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine-induced rat mammary gland tumors.
9879772
1998
×
Entrez Id:
598
Gene Symbol:
BCL2L1
BCL2L1
0.300
Biomarker
disease
CTD_human
Altered bcl-2 family expression during non-genotoxic hepatocarcinogenesis in mice.
10426811
1999
×
Entrez Id:
596
Gene Symbol:
BCL2
BCL2
0.300
Biomarker
disease
CTD_human
Altered bcl-2 family expression during non-genotoxic hepatocarcinogenesis in mice.
10426811
1999
×
Entrez Id:
5743
Gene Symbol:
PTGS2
PTGS2
0.300
Biomarker
disease
CTD_human
Increased cyclooxygenase-2 expression in human pancreatic carcinomas and cell lines: growth inhibition by nonsteroidal anti-inflammatory drugs.
10485483
1999
×
Entrez Id:
3845
Gene Symbol:
KRAS
KRAS
0.360
Biomarker
disease
CTD_human
Strain-dependent lung tumor formation in mice transplacentally exposed to 3-methylcholanthrene and post-natally exposed to butylated hydroxytoluene.
10545420
1999
×
Entrez Id:
7048
Gene Symbol:
TGFBR2
TGFBR2
0.300
Biomarker
disease
CTD_human
A dominant negative mutation of transforming growth factor-beta receptor type II gene in microsatellite stable oesophageal carcinoma.
10789724
2000
×
Entrez Id:
7157
Gene Symbol:
TP53
TP53
0.370
GeneticVariation
disease
BEFREE
Alteration of the p53 gene of lung carcinomas with sarcomatous transformation (spindle cell carcinoma ): analysis of four cases.
10846548
1996
×
Entrez Id:
6648
Gene Symbol:
SOD2
SOD2
0.300
Biomarker
disease
CTD_human
Overexpression of manganese superoxide dismutase mRNA may correlate with aggressiveness in gastric and colorectal adenocarcinomas.
10853026
2000
×
Entrez Id:
6648
Gene Symbol:
SOD2
SOD2
0.300
Biomarker
disease
CTD_human
Reduced expression of manganese superoxide dismutase mRNA may correlate with invasiveness in esophageal carcinoma.
11053990
2000